Hydrochloric Acid → Vafidemstat

HRID 709417Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 709417
Cl.[CH2:2]([O:9][C:10]1[CH:15]=[CH:14][C:13]([C@@H:16]2[CH2:18][C@H:17]2[NH:19][CH2:20][C:21]2[O:25][C:24]([NH:26]C(=O)OC(C)(C)C)=[N:23][N:22]=2)=[CH:12][CH:11]=1)[C:3]1[CH:8]=[CH:7][CH:6]=[CH:5][CH:4]=1>O1CCOCC1>[CH2:2]([O:9][C:10]1[CH:11]=[CH:12][C:13]([C@@H:16]2[CH2:18][C@H:17]2[NH:19][CH2:20][C:21]2[O:25][C:24]([NH2:26])=[N:23][N:22]=2)=[CH:14][CH:15]=1)[C:3]1[CH:8]=[CH:7][CH:6]=[CH:5][CH:4]=1

Komponenten

4

Versuchsvorschrift

HCl in 1, 4 dioxane (1 mL) was added to a solution of tert-butyl (5-((((trans)-2-(4-(benzyloxy)phenyl)cyclopropyl)amino)methyl)-1,3,4-oxadiazol-2-yl)carbamate (100 mg) in 1, 4 dioxane (1 mL) at 0° C. and stirred for 18 h. After completion, the solvent was evaporated and residue was dissolved in water (10 mL), basified with Na2CO3 solution, extracted with EtOAc (3×5 mL) The combined extracts were washed with water (5 mL), brine (5 mL), dried over anhydrous Na2SO4, filtered and evaporated. The crude residue was purified by column chromatography using MeOH: CHCl3 (5:95) as eluent to afford 5-(((trans)-2-(4-(benzyloxy)phenyl)cyclopropylamino)methyl)-1,3,4-oxadiazol-2-amine (40 mg, 52%) as a white solid.

Aufarbeitung

  1. customAfter completion, the solvent was evaporated
  2. dissolutionresidue was dissolved in water (10 mL)
  3. extractionextracted with EtOAc (3×5 mL) The combined extracts
  4. washwere washed with water (5 mL), brine (5 mL)
  5. dry with materialdried over anhydrous Na2SO4
  6. filtrationfiltered
  7. customevaporated
  8. customThe crude residue was purified by column chromatography

Quellen und Nachweise

ORD-Eintrag
ord-0f9e986d65594e9685d284f59c7860f7
Quelldatensatz
uspto-grants-2015_11
Patentnummer
US09181198B2

Notizen zur Reaktion

Wird geladen…